Vertex Pharmaceuticals has a lot of buy and hold ratings, but there aren't any sell ratings from Wall Street analysts. Around ...
Zacks Investment Research on MSN
Vertex Plunges Around 24% in Six Months: How to Play the Stock
Vertex Pharmaceuticals Incorporated VRTX stock has declined 23.6% in the past six months, mainly due to recent pipeline setbacks. In August 2025, Vertex’s phase II study on the oral formulation of ...
Jupiter Endovascular announced today that its Vertex catheter received FDA 510(k) clearance for the insertion of endovascular ...
Vertex Pharmaceuticals Incorporated just reported a robust Q2 with earnings per share of $4.52, surpassing estimates and ...
Vertex Pharmaceuticals Incorporated has grabbed a "Moderate Buy" consensus from the financial wizards. With 27 analysts ...
(BAC) highlights the Vertex® evaporative condenser, where peak reliability meets easy maintenance with enhanced materials, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback